Enhabit Outperforms Medical Peers This Year with 23.2% YTD Return

Enhabit, Inc. (EHAB) is outperforming its peers in the Medical sector, with a 23.2% year-to-date gain compared to the sector's 5.8% gain. The company has a Zacks Rank of #2 (Buy) and its full-year earnings estimate has increased 12.4% in the past three months. Another Medical stock outperforming the sector is Gain Therapeutics, Inc. (GANX), which has gained 87.5% year-to-date and has a Zacks Rank of #2 (Buy).